Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea

被引:15
作者
Cho, Yongil [1 ]
Park, Hyun Soo [2 ]
机构
[1] Hanyang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea
[2] Jeju Natl Univ, Dept Emergency Med, Sch Med, Jeju, South Korea
来源
BMJ OPEN | 2018年 / 8卷 / 09期
关键词
fluoroquinolone; ventricular arrhythmia; torsades de pointes; population-based study; TORSADES-DE-POINTES; QT-INTERVAL PROLONGATION; FLUOROQUINOLONE USE; CARDIAC-ARRHYTHMIA; AORTIC DISSECTION; AZITHROMYCIN;
D O I
10.1136/bmjopen-2017-020974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate whether oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin increase the risk of ventricular arrhythmia in Korea's general population. Design Population-based cohort study using administrative claims data on a national scale in Korea. Setting All primary, secondary and tertiary care settings from 1 January 2015 to 31 December 2015. Participants Patients who were prescribed the relevant study medications at outpatient visits. Primary outcome measures Each patient group that was prescribed ciprofloxacin, levofloxacin, ofloxacin or moxifloxacin was compared with the group that was prescribed cefixime to assess the risk of serious ventricular arrhythmia (ventricular tachycardia, fibrillation, flutter and cardiac arrest). Using logistic regression analysis with inverse probability of treatment weighting using the propensity score, OR and 95% CI for serious ventricular arrhythmia were calculated for days 1-7 and 8-14 after the patients commenced antibiotic use. Results During the study period, 4 888 890 patients were prescribed the study medications. They included 1 466 133 ciprofloxacin users, 1 141 961 levofloxacin users, 1 830 786 ofloxacin users, 47080 moxifloxacin users and 402930 cefixime users. Between 1 and 7 days after index date, there was no evidence of increased serious ventricular arrhythmia related to the prescription of ciprofloxacin (OR 0.72; 95% CI 0.49 to 1.06) and levofloxacin (OR 0.92; 95% CI 0.66 to 1.29). Ofloxacin had a 59% reduced risk of serious ventricular arrhythmia compared with cefixime during 1-7 days after prescription. Whereas the OR of serious ventricular arrhythmia after the prescription of moxifloxacin was 1.87 (95% CI 1.15 to 3.11) compared with cefixime during 1-7 days after prescription. Conclusions During 1-7 days after prescription, ciprofloxacin and levofloxacin were not associated with increased risk and ofloxacin showed reduced risk of serious ventricular arrhythmia. Moxifloxacin increased the risk of serious ventricular arrhythmia.
引用
收藏
页数:8
相关论文
共 40 条
  • [1] Antibiotic-induced Cardiac Arrhythmias
    Abo-Salem, Elsayed
    Fowler, John C.
    Attari, Mehran
    Cox, Craig D.
    Perez-Verdia, Alejandro
    Panikkath, Ragesh
    Nugent, Kenneth
    [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (01) : 19 - 25
  • [2] Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
    Austin, Peter C.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (25) : 3083 - 3107
  • [3] The effect of moxifloxacin on QTc and implications for the design of thorough QT studies
    Bloomfield, D. M.
    Kost, J. T.
    Ghosh, K.
    Hreniuk, D.
    Hickey, L. A.
    Guitierrez, M. J.
    Gottesdiener, K.
    Wagner, J. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 475 - 480
  • [4] Propensity Score Methods for Confounding Control in Nonexperimental Research
    Brookhart, M. Alan
    Wyss, Richard
    Layton, J. Bradley
    Stuerner, Til
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (05): : 604 - 611
  • [5] Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study
    Chou, Hsu-Wen
    Wang, Jiun-Ling
    Chang, Chia-Hsuin
    Lai, Chao-Lun
    Lai, Mei-Shu
    Chan, K. Arnold
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) : 566 - 577
  • [6] Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance
    Cubeddu, Luigi X.
    [J]. CURRENT CARDIOLOGY REVIEWS, 2009, 5 (03) : 166 - 176
  • [7] Moxifloxacin and torsaide de Pointes
    Dale, Krista M.
    Lertsburapa, Kirkeith
    Kluger, Jeffrey
    White, C. Michael
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (02) : 336 - 340
  • [8] Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study
    Daneman, Nick
    Lu, Hong
    Redelmeier, Donald A.
    [J]. BMJ OPEN, 2015, 5 (11):
  • [9] Daya Samantapudi K, 2004, Am J Ther, V11, P77, DOI 10.1097/00045391-200401000-00014
  • [10] Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
    Démolis, JL
    Kubitza, D
    Tennezé, L
    Funck-Brentano, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 658 - 666